These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16825271)

  • 1. Oral magnesium therapy, exercise heart rate, exercise tolerance, and myocardial function in coronary artery disease patients.
    Pokan R; Hofmann P; von Duvillard SP; Smekal G; Wonisch M; Lettner K; Schmid P; Shechter M; Silver B; Bachl N
    Br J Sports Med; 2006 Sep; 40(9):773-8. PubMed ID: 16825271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oral magnesium therapy on exercise tolerance, exercise-induced chest pain, and quality of life in patients with coronary artery disease.
    Shechter M; Bairey Merz CN; Stuehlinger HG; Slany J; Pachinger O; Rabinowitz B
    Am J Cardiol; 2003 Mar; 91(5):517-21. PubMed ID: 12615252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral magnesium therapy improves endothelial function in patients with coronary artery disease.
    Shechter M; Sharir M; Labrador MJ; Forrester J; Silver B; Bairey Merz CN
    Circulation; 2000 Nov; 102(19):2353-8. PubMed ID: 11067788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasting blood glucose levels are related to exercise capacity in patients with coronary artery disease.
    Van de Veire NR; De Winter O; Gir M; De Buyzere M; Van de Wiele C; De Sutter J
    Am Heart J; 2006 Sep; 152(3):486-92. PubMed ID: 16923418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oral amino acid supplementation on myocardial function in patients with type 2 diabetes mellitus.
    Scognamiglio R; Negut C; Piccolotto R; Dioguardi FS; Tiengo A; Avogaro A
    Am Heart J; 2004 Jun; 147(6):1106-12. PubMed ID: 15199363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximum oxygen uptake at peak exercise in elderly patients with coronary artery disease and preserved left ventricular function: the role of inflammation on top of tissue Doppler-derived systolic and diastolic function.
    Van de Veire NR; De Winter O; Philippé J; De Buyzere M; Bernard D; Langlois M; Gillebert TC; De Sutter J
    Am Heart J; 2006 Aug; 152(2):297.e1-7. PubMed ID: 16875912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of peripheral endothelial dysfunction by acute vitamin C application: different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy.
    Erbs S; Gielen S; Linke A; Möbius-Winkler S; Adams V; Baither Y; Schuler G; Hambrecht R
    Am Heart J; 2003 Aug; 146(2):280-5. PubMed ID: 12891196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral H2-receptor antagonists on left ventricular systolic function and exercise capacity in patients with chronic stable heart failure.
    Lucas BD; Williams MA; Mohiuddin SM; LaMadrid LJ; Schroeder LJ; Hilleman DE
    Pharmacotherapy; 1998; 18(4):824-30. PubMed ID: 9692655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) study.
    Fox K; Ferrari R; Tendera M; Steg PG; Ford I;
    Am Heart J; 2006 Nov; 152(5):860-6. PubMed ID: 17070146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study.
    Conraads VM; Metra M; Kamp O; De Keulenaer GW; Pieske B; Zamorano J; Vardas PE; Böhm M; Dei Cas L
    Eur J Heart Fail; 2012 Feb; 14(2):219-25. PubMed ID: 22147202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockade and exercise capacity in patients with mitral stenosis in sinus rhythm.
    Monmeneu Menadas JV; Marín Ortuño F; Reyes Gomis F; Jordán Torrent A; García Martínez M; Bodí Peris V; García de Burgos de Rico E
    J Heart Valve Dis; 2002 Mar; 11(2):199-203. PubMed ID: 12000160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of exercise training on vascular endothelial function in patients with stable coronary artery disease: a randomized controlled trial.
    Luk TH; Dai YL; Siu CW; Yiu KH; Chan HT; Lee SW; Li SW; Fong B; Wong WK; Tam S; Lau CP; Tse HF
    Eur J Prev Cardiol; 2012 Aug; 19(4):830-9. PubMed ID: 21724681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of a randomized trial on the effectiveness of aerobic interval training in patients with coronary artery disease: the SAINTEX-CAD study.
    Conraads VM; Van Craenenbroeck EM; Pattyn N; Cornelissen VA; Beckers PJ; Coeckelberghs E; De Maeyer C; Denollet J; Frederix G; Goetschalckx K; Hoymans VY; Possemiers N; Schepers D; Shivalkar B; Vanhees L
    Int J Cardiol; 2013 Oct; 168(4):3532-6. PubMed ID: 23711446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular function.
    Bertrand ME; Remme WJ; Fox KM; Ferrari R; Simoons ML;
    Int J Cardiol; 2007 Sep; 121(1):57-61. PubMed ID: 17270296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease.
    Magyar K; Halmosi R; Palfi A; Feher G; Czopf L; Fulop A; Battyany I; Sumegi B; Toth K; Szabados E
    Clin Hemorheol Microcirc; 2012; 50(3):179-87. PubMed ID: 22240353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of exercise prescription on daily physical activity and maximal exercise capacity in coronary artery disease patients with and without type 2 diabetes.
    Karjalainen JJ; Kiviniemi AM; Hautala AJ; Niva J; Lepojärvi S; Mäkikallio TH; Piira OP; Huikuri HV; Tulppo MP
    Clin Physiol Funct Imaging; 2012 Nov; 32(6):445-54. PubMed ID: 23031065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral amino acid supplements improve exercise capacities in elderly patients with chronic heart failure.
    Aquilani R; Viglio S; Iadarola P; Opasich C; Testa A; Dioguardi FS; Pasini E
    Am J Cardiol; 2008 Jun; 101(11A):104E-110E. PubMed ID: 18514618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial.
    von Haehling S; Schefold JC; Jankowska EA; Springer J; Vazir A; Kalra PR; Sandek A; Fauler G; Stojakovic T; Trauner M; Ponikowski P; Volk HD; Doehner W; Coats AJ; Poole-Wilson PA; Anker SD
    J Am Coll Cardiol; 2012 Feb; 59(6):585-92. PubMed ID: 22300693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of vitamin C on endothelial function and exercise capacity in patients with a Fontan circulation.
    Goldstein BH; Sandelin AM; Golbus JR; Warnke N; Gooding L; King KK; Donohue JE; Yu S; Gurney JG; Goldberg CS; Rocchini AP; Charpie JR
    Congenit Heart Dis; 2012; 7(3):226-34. PubMed ID: 22176653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
    J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.